XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Other Comprehensive Loss
Retained Earning/ (Accumulated Deficit)
Balance at Dec. 31, 2020 $ 547,801 $ 82 $ 612,879   $ (65,160)
Balance, shares at Dec. 31, 2020   82,436,937      
Issuance of common stock upon exercise of stock options 471 $ 1 470    
Issuance of common stock upon exercise of stock options, shares   300,000      
Stock-based compensation expense 7,273   7,273    
Net income (loss) 30,713       30,713
Balance at Mar. 31, 2021 586,258 $ 83 620,622   (34,447)
Balance, shares at Mar. 31, 2021   82,736,937      
Balance at Dec. 31, 2020 547,801 $ 82 612,879   (65,160)
Balance, shares at Dec. 31, 2020   82,436,937      
Net income (loss) 4,058        
Balance at Sep. 30, 2021 581,452 $ 83 642,471   (61,102)
Balance, shares at Sep. 30, 2021   83,047,079      
Balance at Mar. 31, 2021 586,258 $ 83 620,622   (34,447)
Balance, shares at Mar. 31, 2021   82,736,937      
Issuance of common stock upon exercise of stock options 57   57    
Issuance of common stock upon exercise of stock options, shares   40,000      
Stock-based compensation expense 10,007   10,007    
Net income (loss) 1,539       1,539
Balance at Jun. 30, 2021 597,861 $ 83 630,686   (32,908)
Balance, shares at Jun. 30, 2021   82,776,937      
Issuance of common stock upon exercise of stock options 795   795    
Issuance of common stock upon exercise of stock options, shares   270,142      
Stock-based compensation expense 10,990   10,990    
Net income (loss) (28,194)       (28,194)
Balance at Sep. 30, 2021 581,452 $ 83 642,471   (61,102)
Balance, shares at Sep. 30, 2021   83,047,079      
Balance at Dec. 31, 2021 710,077 $ 83 653,964   56,030
Balance, shares at Dec. 31, 2021   83,102,730      
Issuance of common stock upon exercise of stock options 223   223    
Issuance of common stock upon exercise of stock options, shares   154,861      
Stock-based compensation expense 11,661   11,661    
Net income (loss) (42,077)       (42,077)
Balance at Mar. 31, 2022 679,884 $ 83 665,848   13,953
Balance, shares at Mar. 31, 2022   83,257,591      
Balance at Dec. 31, 2021 710,077 $ 83 653,964   56,030
Balance, shares at Dec. 31, 2021   83,102,730      
Net income (loss) (81,478)        
Balance at Sep. 30, 2022 663,187 $ 83 689,407 $ (855) (25,448)
Balance, shares at Sep. 30, 2022   83,287,639      
Balance at Mar. 31, 2022 679,884 $ 83 665,848   13,953
Balance, shares at Mar. 31, 2022   83,257,591      
Stock-based compensation expense 11,908   11,908    
Net income (loss) (31,335)       (31,335)
Balance at Jun. 30, 2022 660,457 $ 83 677,756   (17,382)
Balance, shares at Jun. 30, 2022   83,257,591      
Issuance of common stock upon exercise of stock options 7   7    
Issuance of common stock upon exercise of stock options, shares   1,012      
Issuance of common stock under ESPP 140   140    
Issuance of common stock under ESPP, shares   29,036      
Stock-based compensation expense 11,504   11,504    
Other comprehensive loss (855)     (855)  
Net income (loss) (8,066)       (8,066)
Balance at Sep. 30, 2022 $ 663,187 $ 83 $ 689,407 $ (855) $ (25,448)
Balance, shares at Sep. 30, 2022   83,287,639